KEI Comments on Exclusive License of Zika Strain to AARI

On October 14, 2025, Knowledge Ecology International (KEI) provided the NIH with comments regarding the “Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Development of Zika Virus Strains for Use in Oncolytic Therapy” (90 FR 46414) to Advocate Aurora Research… Continue Reading

WHO IGWG3 – KEI’s statement at opening, focuses on transparency, technology transfer and pricing of products, WHO pathogen access and benefit sharing system (PABS) negotiations

On Monday, 3 November 2025, Knowledge Ecology International (KEI) delivered the following intervention at the Third meeting of the open-ended Intergovernmental Working Group on the WHO Pandemic Agreement. Given the significant attacks on the WHO and the importance of restoring… Continue Reading